Neurotropic peptide HLDF-6-amide reduces age-related decline in sexual activity in old male rats-Reference-Cited by-同舟云学术

Neurotropic peptide HLDF-6-amide reduces age-related decline in sexual activity in old male rats

Published:2021-07 Issue: Volume:149 Page:111329
ISSN:0531-5565
Container-title:Experimental Gerontology
language:en
Short-container-title:Experimental Gerontology

Author:

Sokolov O.Yu,Prokhorova T.A.,Tereshkina E.B.,Zozulya S.A.,Simonov A.N.,Kost N.V.,Dadayan A.K.,Bogachouk A.P.,Zolotarev Yu.A

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Genetics,Molecular Biology,Ageing,Biochemistry

Reference13 articles.

1. Reinforcing properties of ejaculation in the male rat: role of opioids and dopamine;Ågmo;Behav Neurosci.,1990

2. Comparative study of the neuroprotective and nootropic activities of the carboxylate and amide forms of the HLDF-6 peptide in animal models of Alzheimer's disease;Bogachouk;J Psychopharmacol.,2016

3. The administration of Semax and HLDF-6 peptides to rats regulates protein synthesis rhythm in hepatocytes and corrects senescent disturbances;Brodsky;RusJDevBiol.,2020

4. Modulation of functional macrophage activity by HLDF6 peptide upon adding opiate receptor agonists;Danilenko;Med. Immunol.,2005

5. Neuroprotective effect of the hexapeptide HLDF-6 on rat hippocampal neurons on the in vivo and in vitro models of Alzheimer’s disease;Kostanyan;Rus. J. Bioorg. Chem.,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Neurotropic and Immunotropic Drugs on Leukocyte Elastase Activity In Vitro;Bulletin of Experimental Biology and Medicine;2024-03

2. HLDF-6-H Peptide Exhibits an Anti-inflammatory Effect in the Development of Depression in an MPTP Model of Parkinson's Disease;Journal Biomed;2023-11-20

3. Neuron- and microglia-specific immunoexpression in steroid-independent male sexual behaviour in castrated B6D2F1 male mice;2022-12-08

4. HLDF-6 peptides exhibit neuroprotective effects in the experimental model of preclinical Parkinson's disease;Neuropeptides;2022-12